AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 149.13 |
Market Cap | 17.06B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 7.44 |
PE Ratio (ttm) | 20.54 |
Forward PE | n/a |
Analyst | Hold |
Ask | 171 |
Volume | 456,833 |
Avg. Volume (20D) | 840,688 |
Open | 153.05 |
Previous Close | 153.27 |
Day's Range | 150.47 - 153.12 |
52-Week Range | 123.04 - 165.32 |
Beta | undefined |
About DGX
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPat...
Analyst Forecast
According to 13 analyst ratings, the average rating for DGX stock is "Hold." The 12-month stock price forecast is $172, which is an increase of 12.56% from the latest price.
Next Earnings Release
Analysts project revenue of $2.58B, reflecting a 12.76% YoY growth and earnings per share of 2.19, making a 1.86% increase YoY.
2 months ago · seekingalpha.com
Quest Diagnostics Has Massive Secular Tailwinds And A Strong BaseQuest Diagnostics benefits from an aging population, driving increased lab testing volumes, particularly in genetic testing, and offers a 2.0% dividend yield. DGX's M&A strategy, including the LifeLab...